Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|11|7|623-625

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.11, Iss.7, 2014-09, pp. : 623-625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: (Thematic Issue: Vascular Pathophysiology of Alzheimer`s Disease)

By  

Current Alzheimer Research, Vol. 11, Iss. 1, 2014-01 ,pp. : 1-3

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Prevention Strategies Targeting Different Preclinical Stages of Alzheimer’s Disease)

By  

Current Alzheimer Research, Vol. 12, Iss. 6, 2015-01 ,pp. : 504-506

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer,s Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?

By  

Current Alzheimer Research, Vol. 13, Iss. 4, 2016-04 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Translational Alzheimer’s Disease Research)

By  

Current Alzheimer Research, Vol. 13, Iss. 3, 2016-03 ,pp. : 214-214

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets)

By  

Current Alzheimer Research, Vol. 14, Iss. 1, 2017-01 ,pp. : 2-5

Bentham Science Publishers

Access to resources Recommend Favorite